journal article·2024-08-30Open access

Anticancer Properties of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Potential Agonists 4-Thiazolidinone-Pyrazoline Hybrids Les-4368 and Les-4370 in Colorectal Adenocarcinoma Cells In Vitro

Edyta Kaleniuk, Serhii Holota, Bartosz Skóra, Dmytro Khylyuk, Anna Tabęcka-Łonczyńska, Roman Lesyk, Konrad A. Szychowski

Applied Sciences· Volume 14· Issue 17

Abstract

Presently, a major challenge is the search for new compounds that may exhibit an inhibitory effect on tumor progression. Recently, the 4-thiazolidinone (4-TZD) group has gained attention in this research field. The aim of the present study was to evaluate the anticancer effects of two new 4-TZD-based derivatives (Z)-5-[5-(2-hydroxyphenyl)- (Les- 4368) and (Z)-5-[5-(4-dimethylaminophenyl)-3-phenyl-4,5-dihydropyrazol-1-ylmethylene]-3-(3-acetoxyphenyl)-2-thioxothiazolidin-4-ones (Les-4370) on peroxisome proliferator-activated receptor gamma (PPARγ)-dependent cytotoxicity in human colorectal adenocarcinoma cells (CACO-2) and in normal human fibroblasts (BJ) in vitro. Les-4368 and Les-4370 exerted a toxic effect on both tested cell lines in high (micromolar) concentrations (10–100 µM). In addition, Les-4368 and Les-4370 applied in the BJ and CACO-2 cells in the concentration range of 10 µM to 100 µM increased the activity of caspase-3 and the production of reactive oxygen species (ROSs). The mRNA expression of PPARγ-related genes (PPARγ, AhR, PXR, and NF-κB) showed certain changes in these parameters, proving the engagement of this receptor in the induction of the biological effects of both tested 4-TZD derivatives. Moreover, the treatment of the BJ and CACO-2 cells with Les-4368, Les-4370, an antagonist (GW9662), or an agonist (rosiglitazone) of the PPARγ receptor also resulted in changes in the above-mentioned parameters. Unfortunately, the tested substances studied cell line work in a non-selective way at a relatively high concentration, which reduces their potential for clinical application. Our research is the preliminary study with the use of these compounds and requires further studies to elucidate the mechanisms of action of their anticancer potential.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Peroxisome Proliferator-Activated Receptors · Quinazolinone synthesis and applications · Metabolism, Diabetes, and Cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotechnology and Cell Biology, University of Information Technology and Management in Rzeszow, St. Sucharskiego 2, 35-225 Rzeszow, Poland

Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, St. Pekarska 69, 79010 Lviv, Ukraine

Department of Organic Chemistry and Pharmacy, Lesya Ukrainka Volyn National University, Volya Avenue 13, 43025 Lutsk, Ukraine

Department of Organic Chemistry, Medical University of Lublin, Aleje Racławickie 1, 20-059 Lublin, Poland

Funding

University of Information Technology and Management in Rzeszow · Ministry of Health of Ukraine

References (58)

Show source-provided references
1. Fontana, F., Anselmi, M., and Limonta, P. (2022). Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression. Cancers, 14.10.3390/cancers14071614 ↗
2. Cancer Statistics, 202210.3322/caac.21708 ↗
3. Ursolic Acid Enhances the Therapeutic Effects of Oxaliplatin in Colorectal Cancer by Inhibition of Drug Resistance10.1111/cas.13425 ↗
4. New Approaches and Procedures for Cancer Treatment: Current Perspectives10.1177/20503121211034366 ↗
5. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
6. Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci., 21.10.3390/ijms21093233 ↗
7. Heterocycles in Drugs and Drug Discovery10.1007/s10593-012-0960-z ↗
8. Roszczenko, P., Holota, S., Szewczyk, O.K., Dudchak, R., Bielawski, K., Bielawska, A., and Lesyk, R. (2022). 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. Int. J. Mol. Sci., 23.10.3390/ijms232113135 ↗
9. Study of Novel Anticancer 4-Thiazolidinone Derivatives10.1016/j.cbi.2016.12.008 ↗
10. New 4-Thiazolidinone-Based Molecules Les-2769 and Les-3266 as Possible PPARγ Modulators10.1016/j.bioorg.2022.106075 ↗
11. Skóra, B., Lewińska, A., Kryshchyshyn-Dylevych, A., Kaminskyy, D., Lesyk, R., and Szychowski, K.A. (2022). Evaluation of Anticancer and Antibacterial Activity of Four 4-Thiazolidinone-Based Derivatives. Molecules, 27.10.3390/molecules27030894 ↗
12. Anticancer Properties of 5Z-(4-Fluorobenzylidene)-2-(4-Hydroxyphenylamino)-Thiazol-4-One10.1038/s41598-019-47177-6 ↗
13. PPARγ Activation by Thiazolidinediones (TZDs) May Modulate Breast Carcinoma Outcome: The Importance of Interplay with TGFβ Signalling10.1111/j.1582-4934.2007.00003.x ↗
14. An Overview on Biological Mechanisms of PPARs10.1016/j.phrs.2004.07.012 ↗
15. Augimeri, G., and Bonofiglio, D. (2021). PPARgamma: A Potential Intrinsic and Extrinsic Molecular Target for Breast Cancer Therapy. Biomedicines, 9.10.3390/biomedicines9050543 ↗
16. Fused Thiopyrano[2,3-d]Thiazole Derivatives as Potential Anticancer Agents10.3797/scipharm.1204-02 ↗
17. Anticancer Properties of 4-Thiazolidinone Derivatives Depend on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)10.1016/j.ejmech.2017.09.071 ↗
18. The Aryl Hydrocarbon Receptor: An Environmental Sensor Integrating Immune Responses in Health and Disease10.1038/s41577-019-0125-8 ↗
19. Guarnieri, T. (2020). Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer. Int. J. Mol. Sci., 21.10.3390/ijms21155264 ↗
20. Huang, Y., He, J., Liang, H., Hu, K., Jiang, S., Yang, L., Mei, S., Zhu, X., Yu, J., and Kijlstra, A. (2018). Aryl Hydrocarbon Receptor Regulates Apoptosis and Inflammation in a Murine Model of Experimental Autoimmune Uveitis. Front. Immunol., 9.10.3389/fimmu.2018.01713 ↗
21. Hallmarks of Cancer: The next Generation10.1016/j.cell.2011.02.013 ↗
22. The Role of the Aryl Hydrocarbon Receptor in Normal and Malignant B Cell Development10.1007/s00281-013-0390-8 ↗
23. The RelA NF-KappaB Subunit and the Aryl Hydrocarbon Receptor (AhR) Cooperate to Transactivate the c-Myc Promoter in Mammary Cells10.1038/sj.onc.1203945 ↗
24. Overexpression of Aryl Hydrocarbon Receptor in Human Lung Carcinomas10.1080/01926230309746 ↗
25. Microarray Analysis of Gene Expression in Metastatic Gastric Cancer Cells after Incubation with the Methylation Inhibitor 5-Aza-2’-Deoxycytidine10.1007/s10585-005-1043-7 ↗
26. Wang, Z., Snyder, M., Kenison, J.E., Yang, K., Lara, B., Lydell, E., Bennani, K., Novikov, O., Federico, A., and Monti, S. (2021). How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression. Int. J. Mol. Sci., 22.10.3390/ijms22010387 ↗
27. Aryl Hydrocarbon Receptor (AhR) Regulates Adipocyte Differentiation by Assembling CRL4B Ubiquitin Ligase to Target PPARγ for Proteasomal Degradation10.1074/jbc.RA119.009282 ↗
28. Induction of Cyp450 Enzymes by 4-Thiazolidinone-Based Derivatives in 3T3-L1 Cells in Vitro10.1007/s00210-020-02025-7 ↗
29. 5-Ene-4-Thiazolidinones Induce Apoptosis in Mammalian Leukemia Cells10.1016/j.ejmech.2016.03.089 ↗
30. Antiproliferative Effect of Elastin-Derived Peptide VGVAPG on SH-SY5Y Neuroblastoma Cells10.1007/s12640-019-00040-y ↗
31. Identification and Inhibition of the ICE/CED-3 Protease Necessary for Mammalian Apoptosis10.1038/376037a0 ↗
32. Epidermal Growth Factor-Labeled Liposomes as a Way to Target the Toxicity of Silver Nanoparticles into EGFR-Overexpressing Cancer Cells in Vitro10.1016/j.taap.2022.116009 ↗
33. Szychowski, K.A., Skóra, B., Kryshchyshyn-Dylevych, A., Kaminskyy, D., Khyluk, D., and Lesyk, R. (2021). 4-Thiazolidinone-Based Derivatives Rosiglitazone and Pioglitazone Affect the Expression of Antioxidant Enzymes in Different Human Cell Lines. Biomed. Pharmacother., 139.10.1016/j.biopha.2021.111684 ↗
34. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding10.1016/0003-2697(76)90527-3 ↗
35. Finiuk, N., Kaleniuk, E., Holota, S., Stoika, R., Lesyk, R., and Szychowski, K.A. (2023). Pyrrolidinedione-Thiazolidinone Hybrid Molecules with Potent Cytotoxic Effect in Squamous Cell Carcinoma SCC-15 Cells. Bioorganic Med. Chem., 92.10.1016/j.bmc.2023.117442 ↗
36. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings10.1021/acs.jcim.1c00203 ↗
37. Yamamoto, K., Tamura, T., Nakamura, R., Hosoe, S., Matsubara, M., Nagata, K., Kodaira, H., Uemori, T., Takahashi, Y., and Suzuki, M. (2019). Development of a Novel Class of Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Ligands as an Anticancer Agent with a Unique Binding Mode Based on a Non-Thiazolidinedione Scaffold. Bioorg. Med. Chem., 27.10.1016/j.bmc.2019.115122 ↗
38. Cryo-EM Structure of the Agonist-Bound Hsp90-XAP2-AHR Cytosolic Complex10.1038/s41467-022-34773-w ↗
39. Avogadro: An Advanced Semantic Chemical Editor, Visualization, and Analysis Platform10.1186/1758-2946-4-17 ↗
40. The Differential Interactions of Peroxisome Proliferator-Activated Receptor γ Ligands with Tyr473 Is a Physical Basis for Their Unique Biological Activities10.1124/mol.107.041202 ↗
41. 4-Thiazolidinone Derivative Les-3833 Effectively Inhibits Viability of Human Melanoma Cells through Activating Apoptotic Mechanisms10.3325/cmj.2017.58.129 ↗
42. Implication of Intracellular ROS Formation, Caspase-3 Activation and Egr-1 Induction in Platycodon D-Induced Apoptosis of U937 Human Leukemia Cells10.1016/j.biopha.2008.08.001 ↗
43. Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species10.1016/j.bbamcr.2016.09.012 ↗
44. Eskandari, E., and Eaves, C.J. (2022). Paradoxical Roles of Caspase-3 in Regulating Cell Survival, Proliferation, and Tumorigenesis. J. Cell Biol., 221.10.1083/jcb.202201159 ↗
45. Differential Pro-Apoptotic Effects of Synthetic 4-Thiazolidinone Derivative Les-3288, Doxorubicin and Temozolomide in Human Glioma U251 Cells10.3325/cmj.2017.58.150 ↗
46. Caspase Activation Pathways: Some Recent Progress10.1038/cdd.2009.59 ↗
47. Nox2-Derived ROS in PPARγ Signaling and Cell-Cycle Progression of Lung Alveolar Epithelial Cells10.1016/j.freeradbiomed.2011.05.027 ↗
48. Grishanova, A.Y., and Perepechaeva, M.L. (2022). Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance. Int. J. Mol. Sci., 23.10.3390/ijms23126719 ↗
49. Kosińska, K., Skóra, B., Holota, S., Shepeta, Y., Tabęcka-Łonczyńska, A., Lesyk, R., and Szychowski, K.A. (2024). Role of 4-Thiazolidinone–Pyrazoline/Indoline Hybrids Les-4369 and Les-3467 in BJ and A549 Cell Lines. Cells, 13.10.3390/cells13121007 ↗
50. 4-Thiazolidinone-Based Derivatives Do Not Affect Differentiation of Mouse Embryo Fibroblasts (3T3-L1 Cell Line) into Adipocytes10.1016/j.cbi.2021.109538 ↗
51. Szlachcikowska, D., Tabęcka-Łonczyńska, A., Holota, S., Roman, O., Shepeta, Y., Lesyk, R., and Szychowski, K.A. (2024). Role of Ciminalum-4-Thiazolidinone Hybrids in Molecular NF-ΚB Dependent Pathways. Int. J. Mol. Sci., 25.10.3390/ijms25137329 ↗
52. Role of NF-ΚB and PPAR-γ in Lung Inflammation Induced by Monocyte-Derived Microparticles10.1183/09031936.00023310 ↗
53. Ciglitazone Induces Early Cellular Proliferation and NF-ΚB Transcriptional Activity in Colon Cancer Cells through P65 Phosphorylation10.1016/j.biocel.2004.08.008 ↗
54. Rosiglitazone Alleviates Lipopolysaccharide-Induced Inflammation in RAW264.7 Cells via Inhibition of NF-ΚB and in a PPARγ-Dependent Manner
55. Insights into the Critical Role of the PXR in Preventing Carcinogenesis and Chemotherapeutic Drug Resistance10.7150/ijbs.68724 ↗
56. Mutual Repression between Steroid and Xenobiotic Receptor and NF-KappaB Signaling Pathways Links Xenobiotic Metabolism and Inflammation10.1172/JCI26283 ↗
57. A Gut Feeling of the PXR, PPAR and NF-ΚB Connection10.1111/j.1365-2796.2008.01951.x ↗
58. Pregnane X Receptor Activation Constrains Mucosal NF-ΚB Activity in Active Inflammatory Bowel Disease10.1371/journal.pone.0221924 ↗